TrivarX: Results of Annual General Meeting
Filed with ASX · · 3 pages · English
Earlier from TrivarX
- Pause in Trading
- Medibio Signs Agreement with PwC Australia for ilumen
- MEB successfully completes first Ilumen pilot with Compass
- Medibio Announces Results of Review of Partly Paid Shares
- Fourth Pilot Agreement Signed with Compass Group for ilumen
Later from TrivarX
- Company Update
- Strategic Plan for FDA and CE Mark Approval
- Final Compass Pilot Completed Successfully
- Medibio submits FDA 510K Application to FDA
- Placement and Fully Underwritten Entitlement Offer
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX